Lean/normal‐weight metabolic dysfunction‐associated fatty liver disease is a risk factor for reflux esophagitis-Reference-Cited by-同舟云学术

Lean/normal‐weight metabolic dysfunction‐associated fatty liver disease is a risk factor for reflux esophagitis

Published:2022-06-07 Issue:8 Volume:52 Page:699-711
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Fukunaga Shuhei¹^ORCID,Nakano Dan¹,Tsutsumi Tsubasa¹,Kawaguchi Takumi¹^ORCID,Eslam Mohammed²,Yoshinaga Shinobu³,Abe Hirohiko⁴,Nouno Ryuichi⁴,Joh Seiya⁵,Mitsuyama Keiichi¹,George Jacob²,Torimura Takuji¹

Affiliation:

1. Department of Medicine Division of Gastroenterology Kurume University School of Medicine Kurume Japan

2. Storr Liver Centre Westmead Institute for Medical Research Westmead Hospital and University of Sydney Sydney New South Wales Australia

3. Medical Examination Section Medical Examination Part Facilities Public Utility Foundation Saga Prefectural Health Promotion Foundation Saga Japan

4. Kumamoto Central Hospital Kikuchi Japan

5. Terao Hospital Kumamoto Japan

Funder

National Health and Medical Research Council

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13795

Reference48 articles.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Different Metabolic Obesity Phenotypes and Erosive Esophagitis: A Retrospective Study;Diabetes, Metabolic Syndrome and Obesity;2024-08

2. Metabolic dysfunction associated fatty liver disease in healthy weight individuals;Hepatology International;2024-07-25

3. Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis;Clinical and Molecular Hepatology;2024-07-01

4. MAFLD Is A Ubiquitous Latent Cofactor in Viral- and Alcoholic-related Hepatocellular Carcinoma;Clinical and Molecular Hepatology;2024-05-20

5. MAFLD as part of systemic metabolic dysregulation;Hepatology International;2024-04-09